Jerel Davis
SEC insider (Form 3/4/5 filer). CIK 0001745958. Director at Turnstone Biologics Corp. (TSBX). 5 reported Form 4/5 transactions since Sep 2024; latest on Aug 8, 2025. Located in LOS ANGELES, CA.
Companies Jerel Davis has filed insider reports for
- Turnstone Biologics Corp. (TSBX): Director
Jerel Davis
CIK: 0001745958
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)5 (100.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
TSBX
Turnstone Biologics Corp.
Director
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Aug 8, 2025TSBX
Turnstone Biologics Corp.
Tender OfferIndirect275K shares- - Aug 8, 2025TSBX
Turnstone Biologics Corp.
Tender OfferIndirect2.7M shares- - Aug 8, 2025TSBX
Turnstone Biologics Corp.
Tender OfferIndirect207.5K shares- - Aug 8, 2025TSBX
Turnstone Biologics Corp.
Tender OfferIndirect90.9K shares- - Aug 8, 2025TSBX
Turnstone Biologics Corp.
Tender OfferIndirect82K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 8, 2025 | TSBX Turnstone Biologics Corp. | Tender Offer | 274,990 | - | - | Indirect |
| Aug 8, 2025 | TSBX Turnstone Biologics Corp. | Tender Offer | 2,726,322 | - | - | Indirect |
| Aug 8, 2025 | TSBX Turnstone Biologics Corp. | Tender Offer | 207,486 | - | - | Indirect |
| Aug 8, 2025 | TSBX Turnstone Biologics Corp. | Tender Offer | 90,888 | - | - | Indirect |
| Aug 8, 2025 | TSBX Turnstone Biologics Corp. | Tender Offer | 82,006 | - | - | Indirect |
1-5 of 5 transactions